Biomerica Inc (BMRA)

$2.96 +0.05 (1.72%)
Market Cap 8.58M
Revenue (ttm) 5.31M
Net Income (ttm) -4.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -93.60%
Debt to Equity Ratio 0.00
Volume 25,000
Avg Vol 295,328
Day's Range N/A - N/A
Shares Out 2.95M
Stochastic %K 57%
Beta 0.34
Analysts Strong Buy
Price Target $13.00

Company Profile

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 645 2111
Fax: 949 553 1231
Address:
17571 Von Karman Avenue, Irvine, United States
counter
counter Oct. 23 at 9:33 PM
$YDKG $BMRA NO!,,,YOUR the DUMB ASS for coming in here and calling people names trying to do their best INSTEAD of helping posting possibilities via charts-your DEFIANTLY young-you can see it a mile away-testosterone fear of being wrong-always has to be right to look like a BIG MAN in front of his peers...if you were in Fallujah-I would NEVER have covered you being such an ass!
1 · Reply
counter
counter Oct. 23 at 9:13 PM
$YDKG THIS is why...was one of BEST calls...$BMRA ...pattern recognition...do you actually know how to read a chart...or draw an analysis?
0 · Reply
DunbPuck
DunbPuck Oct. 22 at 2:44 PM
$BMRA let's get it
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Oct. 21 at 5:44 PM
$BMRA
0 · Reply
16Zx10r
16Zx10r Oct. 20 at 6:53 PM
$BMRA Let me get that $3.05-$3.10 buy range....
0 · Reply
pigachu69
pigachu69 Oct. 20 at 3:09 PM
$BMRA after a big dip, its going up. $3.20 already
0 · Reply
JL_TradeZ
JL_TradeZ Oct. 20 at 3:08 PM
🚨(SPECIAL PLAY) $BMRA is slowly heating up again after that Henry Schein partnership news. Float is tiny at 2.8M with insiders owning over 90%, which explains how easily it can moves on light volume. Technically, it’s curling over all EMAs and holding above VWAP with RSI showing strong momentum without being overbought yet. If buyers keep stepping in, this could see a squeeze really soon
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 20 at 1:52 PM
$VRME just the start of a super nova run!🚨🚨🚨 $BYND $OPEN $BETR $BMRA
0 · Reply
orelorel_
orelorel_ Oct. 20 at 8:08 AM
$BMRA Today is going to be interesting prices...🌐
0 · Reply
Greatviews
Greatviews Oct. 19 at 12:45 PM
$BMRA isn’t exactly blowing the doors with sales so why would they need an agreement with Henry Schein? Things that make you go hmmmm…..
1 · Reply
Latest News on BMRA
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.

Oct 16, 2025, 8:19 AM EDT - 9 days ago

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.

Biomerica Reports First Quarter Fiscal 2026 Financial Results

Oct 15, 2025, 9:27 AM EDT - 10 days ago

Biomerica Reports First Quarter Fiscal 2026 Financial Results

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Oct 8, 2025, 8:19 AM EDT - 17 days ago

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

Sep 9, 2025, 8:08 AM EDT - 6 weeks ago

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use

Sep 3, 2025, 8:19 AM EDT - 7 weeks ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use

Biomerica Reports Fiscal 2025 Year End Results

Aug 29, 2025, 5:12 PM EDT - 2 months ago

Biomerica Reports Fiscal 2025 Year End Results

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use

Aug 14, 2025, 8:19 AM EDT - 2 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

Jul 2, 2025, 8:08 AM EDT - 4 months ago

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Jun 26, 2025, 8:19 AM EDT - 4 months ago

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Jun 6, 2025, 9:30 AM EDT - 5 months ago

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

Jun 5, 2025, 8:19 AM EDT - 5 months ago

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

May 22, 2025, 8:19 AM EDT - 5 months ago

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

May 7, 2025, 8:19 AM EDT - 6 months ago

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection

Apr 23, 2025, 8:19 AM EDT - 6 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Apr 17, 2025, 8:19 AM EDT - 6 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Biomerica Announces Reverse Stock Split

Apr 16, 2025, 9:00 AM EDT - 6 months ago

Biomerica Announces Reverse Stock Split

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis

Feb 26, 2025, 8:19 AM EST - 8 months ago

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Feb 19, 2025, 8:19 AM EST - 8 months ago

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

Jan 16, 2025, 10:49 AM EST - 10 months ago

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Jan 16, 2025, 8:19 AM EST - 10 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Jan 15, 2025, 8:19 AM EST - 10 months ago

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nov 21, 2024, 8:19 AM EST - 1 year ago

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Nov 7, 2024, 9:09 AM EST - 1 year ago

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Oct 30, 2024, 8:19 AM EDT - 1 year ago

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Biomerica Reports First Quarter Fiscal 2025 Financial Results

Oct 16, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports First Quarter Fiscal 2025 Financial Results

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Sep 4, 2024, 8:19 AM EDT - 1 year ago

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Biomerica Reports Fiscal 2024 Year End Results

Aug 29, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports Fiscal 2024 Year End Results

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

Jul 1, 2024, 7:47 AM EDT - 1 year ago

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

May 13, 2024, 8:19 AM EDT - 1 year ago

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Apr 29, 2024, 8:19 AM EDT - 1 year ago

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Biomerica provides update on inFoods® IBS expansion

Apr 15, 2024, 7:47 AM EDT - 1 year ago

Biomerica provides update on inFoods® IBS expansion

Biomerica Reports Third Quarter 2024 Financial Results

Apr 12, 2024, 7:23 PM EDT - 1 year ago

Biomerica Reports Third Quarter 2024 Financial Results

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Mar 28, 2024, 8:19 AM EDT - 1 year ago

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Feb 21, 2024, 8:19 AM EST - 1 year ago

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Jan 23, 2024, 8:19 AM EST - 1 year ago

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Biomerica Reports Second Quarter 2024 Financial Results

Jan 16, 2024, 8:19 AM EST - 1 year ago

Biomerica Reports Second Quarter 2024 Financial Results

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Dec 18, 2023, 7:47 AM EST - 2 years ago

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Nov 10, 2023, 8:19 AM EST - 2 years ago

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

Nov 8, 2023, 8:19 AM EST - 2 years ago

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Oct 13, 2023, 1:10 PM EDT - 2 years ago

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Biomerica Reports First Quarter 2024 Financial Results

Oct 13, 2023, 6:39 AM EDT - 2 years ago

Biomerica Reports First Quarter 2024 Financial Results

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test

Sep 26, 2023, 8:19 AM EDT - 2 years ago

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

Aug 28, 2023, 8:19 AM EDT - 2 years ago

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

Biomerica Reports Fiscal 2023 Year End Results

Aug 25, 2023, 5:00 PM EDT - 2 years ago

Biomerica Reports Fiscal 2023 Year End Results

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test

Aug 3, 2023, 8:19 AM EDT - 2 years ago

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

Jun 21, 2023, 8:19 AM EDT - 2 years ago

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

May 18, 2023, 8:19 AM EDT - 2 years ago

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

Biomerica's inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

Apr 17, 2023, 7:47 AM EDT - 2 years ago

Biomerica's inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

Biomerica Reports Q3 Fiscal 2023 Results

Apr 14, 2023, 4:48 PM EDT - 2 years ago

Biomerica Reports Q3 Fiscal 2023 Results

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

Mar 8, 2023, 8:19 AM EST - 2 years ago

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

counter
counter Oct. 23 at 9:33 PM
$YDKG $BMRA NO!,,,YOUR the DUMB ASS for coming in here and calling people names trying to do their best INSTEAD of helping posting possibilities via charts-your DEFIANTLY young-you can see it a mile away-testosterone fear of being wrong-always has to be right to look like a BIG MAN in front of his peers...if you were in Fallujah-I would NEVER have covered you being such an ass!
1 · Reply
counter
counter Oct. 23 at 9:13 PM
$YDKG THIS is why...was one of BEST calls...$BMRA ...pattern recognition...do you actually know how to read a chart...or draw an analysis?
0 · Reply
DunbPuck
DunbPuck Oct. 22 at 2:44 PM
$BMRA let's get it
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Oct. 21 at 5:44 PM
$BMRA
0 · Reply
16Zx10r
16Zx10r Oct. 20 at 6:53 PM
$BMRA Let me get that $3.05-$3.10 buy range....
0 · Reply
pigachu69
pigachu69 Oct. 20 at 3:09 PM
$BMRA after a big dip, its going up. $3.20 already
0 · Reply
JL_TradeZ
JL_TradeZ Oct. 20 at 3:08 PM
🚨(SPECIAL PLAY) $BMRA is slowly heating up again after that Henry Schein partnership news. Float is tiny at 2.8M with insiders owning over 90%, which explains how easily it can moves on light volume. Technically, it’s curling over all EMAs and holding above VWAP with RSI showing strong momentum without being overbought yet. If buyers keep stepping in, this could see a squeeze really soon
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 20 at 1:52 PM
$VRME just the start of a super nova run!🚨🚨🚨 $BYND $OPEN $BETR $BMRA
0 · Reply
orelorel_
orelorel_ Oct. 20 at 8:08 AM
$BMRA Today is going to be interesting prices...🌐
0 · Reply
Greatviews
Greatviews Oct. 19 at 12:45 PM
$BMRA isn’t exactly blowing the doors with sales so why would they need an agreement with Henry Schein? Things that make you go hmmmm…..
1 · Reply
alma356m
alma356m Oct. 17 at 8:05 PM
$BMRA Ends with a green hammer candlestick. A bullish sign.
0 · Reply
alma356m
alma356m Oct. 17 at 7:58 PM
$BMRA Look what happen a couple of days ago during post market. about 1.69M shares traded.....usually don't see that kind of action during post market....something is up.
0 · Reply
makedatbread88
makedatbread88 Oct. 17 at 7:21 PM
$BMRA had news yesterday but no move with a low float Keep an eye here
0 · Reply
alma356m
alma356m Oct. 17 at 6:14 PM
$BMRA put this one on your watchlist!
0 · Reply
alma356m
alma356m Oct. 17 at 6:13 PM
$BMRA here is another one. This may explain why after hours a couple days ago it went up so high good things are happening behind the scenes! https://stockanalysis.com/stocks/bmra/
0 · Reply
alma356m
alma356m Oct. 17 at 6:10 PM
$BMRA here is another one that’s not posted in stock twits news:
0 · Reply
alma356m
alma356m Oct. 17 at 6:08 PM
$BMRA I wonder why Stocktwits 24 did not post this in their news folder? It was released yesterday!
0 · Reply
Expenslvetaste
Expenslvetaste Oct. 17 at 3:21 PM
$BMRA stock is boring and this board is boring!
1 · Reply
Expenslvetaste
Expenslvetaste Oct. 17 at 9:33 AM
$BMRA
2 · Reply
Annet_why_net
Annet_why_net Oct. 16 at 10:16 PM
$BMRA 😎
0 · Reply
Rum3002576
Rum3002576 Oct. 16 at 8:33 PM
$BMRA $IVF $PRAX won’t be long
0 · Reply
alma356m
alma356m Oct. 16 at 8:15 PM
$BMRA Recent Highlights - **Financial Results (Q1 FY2026 :(June 1, 2025 - Aug 31, 2025)):** Reported break‑even EPS ($0.00) vs. a loss last year, improved gross margins, and reduced operating expenses. - **Pipeline Progress:** - **inFoods® IBS** received a CPT/PLA code, paving the way for insurance reimbursement. - **Fortel® Ulcer and Kidney Tests** approved for home use in the UAE, expanding international reach. - **Leadership:** Gary Huff (former LabCorp Diagnostics CEO) joined the board, adding credibility and industry experience. - **Cost Controls:** Operating expenses cut by ~$1.3M year‑over‑year, showing focus on efficiency. Key Takeaways - **Trading Lens:** Still a breakout *candidate* — price action is coiling near $3.00 with resistance at $3.40–$3.50. Needs volume confirmation for a true breakout. - **Investment Lens:** Micro‑cap with ~$3M cash on hand, negative earnings, and dilution risk. Not investable long‑term yet, pipeline progress and approvals are +
0 · Reply